121 related articles for article (PubMed ID: 5117358)
1. [Prevention of neonatal toxoplasmosis. New perspectives].
Biagi F
Prensa Med Mex; 1971 Apr; 36(3):112-4. PubMed ID: 5117358
[No Abstract] [Full Text] [Related]
2. [Theoretical bases of the prevention by spiramycin of congenital toxoplasmosis in pregnant women].
Garin JP; Pellerat J; Maillard ; Woehrle R; Hezez
Presse Med (1893); 1968 Dec; 76(48):2266. PubMed ID: 5720932
[No Abstract] [Full Text] [Related]
3. [Congenital toxoplasmosis. Evaluation of the benefit of prenatal therapy].
Lambotte R
J Gynecol Obstet Biol Reprod (Paris); 1976 Mar; 5(2):265-9. PubMed ID: 993567
[No Abstract] [Full Text] [Related]
4. Toxoplasmosis.
Poindexter HA
J Natl Med Assoc; 1973 Sep; 65(5):399-401 passim. PubMed ID: 4795539
[No Abstract] [Full Text] [Related]
5. [Toxoplasmosis].
Sanz Martin F
Rev Clin Esp; 1972 Feb; 124(3):213-26. PubMed ID: 4554061
[No Abstract] [Full Text] [Related]
6. [Letter: Treatment of toxoplasmosis].
Thibault P
Nouv Presse Med; 1973 Nov; 2(39):2601. PubMed ID: 4793316
[No Abstract] [Full Text] [Related]
7. [Congenital toxoplasmosis; observations on the recommendation of the Public Health Council].
van der Veen J
Ned Tijdschr Geneeskd; 1984 Jan; 128(3):131-3. PubMed ID: 6700748
[No Abstract] [Full Text] [Related]
8. Toxoplasmosis.
Boughton CR
Med J Aust; 1970 Aug; 2(9):418-21. PubMed ID: 5493331
[No Abstract] [Full Text] [Related]
9. [New prospects for the prevention of neonatal toxoplasmosis].
Biagi F
Ginecol Obstet Mex; 1972 Dec; 32(194):611-5. PubMed ID: 4644853
[No Abstract] [Full Text] [Related]
10. [Regular supervision of pregnant women for the prevention of congenital toxoplasmosis].
Kupka S
Zentralbl Gynakol; 1973 Aug; 95(32):1122-5. PubMed ID: 4762317
[No Abstract] [Full Text] [Related]
11. [Prevention of congenital toxoplasmosis. Results at the maternity department of the Hôpital Saint-Antoine in 1972].
Roux C; Desmonts G; Gaulier M; Mulliez N; Hery D
J Gynecol Obstet Biol Reprod (Paris); 1975 Jun; 4(4):557-69. PubMed ID: 1228215
[TBL] [Abstract][Full Text] [Related]
12. [Recent advances in the epidemiology, clinical aspects and therapy of toxoplasmosis].
Tolentino P
Recenti Prog Med; 1970 Jul; 49(1):1-16. PubMed ID: 4921268
[No Abstract] [Full Text] [Related]
13. [Theoretical basis of the prevention of congenital toxoplasmosis in pregnant women by spiramycin].
Garin JP; Pellerat J; Maillard ; Woehrle-Hezez R
Lyon Med; 1969 Jan; 221(1):21-5. PubMed ID: 5781324
[No Abstract] [Full Text] [Related]
14. The significance of Toxoplasma infections for public health.
Meuwissen JH
Ned Tijdschr Geneeskd; 1975 Mar; 119(13):513-4. PubMed ID: 1128715
[No Abstract] [Full Text] [Related]
15. [Apropos of a case of congenital toxoplasmosis].
Lacomme M; Lewin D; Amiel-Tison C; Cheynier JM
Bull Fed Soc Gynecol Obstet Lang Fr; 1967; 19(3):208-13. PubMed ID: 5584037
[No Abstract] [Full Text] [Related]
16. [A case of congenital toxoplasmosis with prolonged drug treatment].
Roland T; Wintgens M
Rev Med Liege; 1965 May; 20(10):287-98. PubMed ID: 5834113
[No Abstract] [Full Text] [Related]
17. [The problems of congenital ocular toxoplasmosis (author's transl)].
Vojtová O; Kouba K; Vedrová D
Klin Monbl Augenheilkd; 1973 Dec; 163(6):732-8. PubMed ID: 4788871
[No Abstract] [Full Text] [Related]
18. [Treatment of toxoplasmosis acquired during pregnancy with spiramycin].
Couvreur J; Desmonts C
Zentralbl Gynakol; 1983; 105(17):1104-7. PubMed ID: 6650001
[No Abstract] [Full Text] [Related]
19. [Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up].
Ambroise-Thomas P; Schweitzer M; Pinon JM; Thiebaugeorges O
Bull Acad Natl Med; 2001; 185(4):665-83; discussion 684-8. PubMed ID: 11503357
[TBL] [Abstract][Full Text] [Related]
20. [Toxoplasmosis during pregnancy and prevention of congenital toxoplasmosis].
Presse Med (1893); 1970 Mar; 78(14):665. PubMed ID: 5440106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
